Evidence map›Paper›PMID 30204838›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Transmission of Mobile Colistin Resistance (mcr-1) by Duodenoscope.

Erica S Shenoy, Virginia M Pierce, Maroya Spalding Walters, Heather Moulton-Meissner, Adrian Lawsin, David Lonsway, Alicia Shugart, Gillian McAllister, Alison Laufer Halpin, Alejandra Zambrano-Gonzalez and 8 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogenic Drug Resistant Fungi: A Review of Mitigation Strategies.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Antimicrobial agents and chemotherapy · 2019
    Article
  12. Phylogenetic Analysis of Multi-Drug ResistantFrontiers in public health · 2019
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Erica S ShenoyDivision of Infectious Diseases, Boston, Massachusetts.
Virginia M PierceMicrobiology Laboratory, Pathology Service, Massachusetts General Hospital, Boston, Massachusetts.
Maroya Spalding WaltersDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Heather Moulton-MeissnerDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Adrian LawsinDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
David LonswayDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Alicia ShugartDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Gillian McAllisterDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Alison Laufer HalpinDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Alejandra Zambrano-GonzalezInfection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.
Erin E RyanInfection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.
Dolores SuslakInfection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.
Alexandra DeJesusBureau of Infectious Disease and Laboratory Sciences, Boston, Massachusetts.
Kerri BartonBureau of Infectious Disease and Laboratory Sciences, Boston, Massachusetts.
Lawrence C MadoffBureau of Infectious Disease and Laboratory Sciences, Boston, Massachusetts.
Eileen McHaleBureau of Health Care Safety and Quality, Massachusetts Department of Public Health, Boston, Massachusetts.
Alfred DeMariaBureau of Infectious Disease and Laboratory Sciences, Boston, Massachusetts.
David C HooperDivision of Infectious Diseases, Boston, Massachusetts.
Centers for Disease Control and Prevention · USMassachusetts Department of Public Health · USMassachusetts General Hospital · USHarvard University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundClinicians increasingly utilize polymyxins for treatment of serious infections caused by multidrug-resistant gram-negative bacteria. Emergence of plasmid-mediated, mobile colistin resistance genes creates potential for rapid spread of polymyxin resistance. We investigated the possible transmission of Klebsiella pneumoniae carrying mcr-1 via duodenoscope and report the first documented healthcare transmission of mcr-1-harboring bacteria in the United States.

methodsA field investigation, including screening targeted high-risk groups, evaluation of the duodenoscope, and genome sequencing of isolated organisms, was conducted. The study site included a tertiary care academic health center in Boston, Massachusetts, and extended to community locations in New England.

resultsTwo patients had highly related mcr-1-positive K. pneumoniae isolated from clinical cultures; a duodenoscope was the only identified epidemiological link. Screening tests for mcr-1 in 20 healthcare contacts and 2 household contacts were negative. Klebsiella pneumoniae and Escherichia coli were recovered from the duodenoscope; neither carried mcr-1. Evaluation of the duodenoscope identified intrusion of biomaterial under the sealed distal cap; devices were recalled to repair this defect.

conclusionsWe identified transmission of mcr-1 in a United States acute care hospital that likely occurred via duodenoscope despite no identifiable breaches in reprocessing or infection control practices. Duodenoscope design flaws leading to transmission of multidrug-resistant organsisms persist despite recent initiatives to improve device safety. Reliable detection of colistin resistance is currently challenging for clinical laboratories, particularly given the absence of a US Food and Drug Administration-cleared test; improved clinical laboratory capacity for colistin susceptibility testing is needed to prevent the spread of mcr-carrying bacteria in healthcare settings.

Indexed as

Drug Resistance, Multiple, BacterialEquipment ContaminationColistinDuodenoscopesHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsUnited StatesColistinduodenoscopeinfection controlKlebsiella pneumoniaemedical device safetymobile colistin resistance

Identifiers

PMID30204838
PMCPMC10849062
OpenAlexW2891117057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.